Karyopharm Therapeutics Inc. Common Stock (NASDAQ: KPTI) last traded at $0.417, down 17.40% on the session. The quote above updates while this page is open; the figures below are drawn from Karyopharm Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Karyopharm Therapeutics Inc. Common Stock trades on NASDAQ under the ticker KPTI. Its market capitalisation is $9.46 million.
Valuation measures for Karyopharm Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.46M |
|---|---|
| Enterprise value | $395.97M |
| Price / sales | 0.06 |
| Beta | 0.53 |
Trailing-twelve-month figures tagged in Karyopharm Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $146.62M |
| Net income (TTM) | -$224.74M |
|---|
| Operating margin | -56.17% |
|---|
| Cash | $54.98M |
|---|
Range and volume for KPTI over the past 52 weeks.
| 52-week high | $10.99 |
|---|---|
| 52-week low | $0.396 |
| Volume | 1.48M |
| Average volume | 1.70M |
| Previous close | $0.505 |
Invest a chosen dollar amount in Karyopharm Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KPTI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.